1. Home
  2. IMNM vs CTBI Comparison

IMNM vs CTBI Comparison

Compare IMNM & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • CTBI
  • Stock Information
  • Founded
  • IMNM 2006
  • CTBI 1903
  • Country
  • IMNM United States
  • CTBI United States
  • Employees
  • IMNM N/A
  • CTBI N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • CTBI Major Banks
  • Sector
  • IMNM Health Care
  • CTBI Finance
  • Exchange
  • IMNM Nasdaq
  • CTBI Nasdaq
  • Market Cap
  • IMNM 747.7M
  • CTBI 888.9M
  • IPO Year
  • IMNM 2020
  • CTBI N/A
  • Fundamental
  • Price
  • IMNM $12.09
  • CTBI $51.48
  • Analyst Decision
  • IMNM Strong Buy
  • CTBI Strong Buy
  • Analyst Count
  • IMNM 4
  • CTBI 2
  • Target Price
  • IMNM $28.75
  • CTBI $47.00
  • AVG Volume (30 Days)
  • IMNM 761.5K
  • CTBI 46.1K
  • Earning Date
  • IMNM 11-07-2024
  • CTBI 10-16-2024
  • Dividend Yield
  • IMNM N/A
  • CTBI 3.67%
  • EPS Growth
  • IMNM N/A
  • CTBI N/A
  • EPS
  • IMNM N/A
  • CTBI 4.40
  • Revenue
  • IMNM $10,784,000.00
  • CTBI $226,756,000.00
  • Revenue This Year
  • IMNM N/A
  • CTBI N/A
  • Revenue Next Year
  • IMNM N/A
  • CTBI $4.10
  • P/E Ratio
  • IMNM N/A
  • CTBI $11.90
  • Revenue Growth
  • IMNM 62.73
  • CTBI 0.94
  • 52 Week Low
  • IMNM $6.93
  • CTBI $35.52
  • 52 Week High
  • IMNM $30.96
  • CTBI $52.76
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 36.69
  • CTBI 62.85
  • Support Level
  • IMNM $11.81
  • CTBI $47.51
  • Resistance Level
  • IMNM $12.44
  • CTBI $52.76
  • Average True Range (ATR)
  • IMNM 0.68
  • CTBI 1.14
  • MACD
  • IMNM -0.11
  • CTBI 0.40
  • Stochastic Oscillator
  • IMNM 11.61
  • CTBI 79.39

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

Share on Social Networks: